Shattuck Labs Closes Up To $103M Private Placement To Fund SL-325 Through Phase 2 Trials, Extends Cash Runway Into 2029; Company Appoints Dan Baker M.D. And OrbiMed's Mona Ashiya Ph.D. To Board Of Directors
Author: Benzinga Newsdesk | August 26, 2025 06:39am